Losartan dose
Pro Research Analysisby 
Searched over 200M research papers for "losartan dose"
Losartan Dose: Efficacy, Pharmacokinetics, and Safety
Introduction to Losartan Dosage
Losartan, an angiotensin II receptor antagonist, is widely used to manage hypertension and protect against end-organ damage. Understanding the optimal dosing of losartan is crucial for maximizing its therapeutic benefits while minimizing adverse effects.
Pharmacokinetics of Losartan
Losartan is rapidly absorbed after oral administration, reaching peak plasma concentrations within 1-2 hours. Approximately 14% of a losartan dose is converted to its active metabolite, EXP3174, which is significantly more potent and has a longer half-life of 6-9 hours . The pharmacokinetics of both losartan and EXP3174 are linear and dose-proportional, remaining consistent with repeated administration .
Dose-Response Relationship in Adults
Blood Pressure Reduction
Studies have shown that losartan reduces blood pressure in a dose-dependent manner. In a study involving doses of 10 to 150 mg, significant reductions in systolic and diastolic blood pressure were observed, with the 50 mg dose producing effects comparable to enalapril 20 mg . Another study demonstrated that doses up to 25 mg resulted in significant vasodilation, but higher doses did not yield additional benefits, suggesting a plateau effect .
Renoprotection in Diabetic Nephropathy
For patients with diabetic nephropathy, losartan doses of 50, 100, and 150 mg all reduced albuminuria and blood pressure. However, the 100 mg dose was found to be the most effective for both renoprotection and blood pressure reduction, without additional benefits at 150 mg .
Dose-Response in Pediatric Populations
Hypertensive Children (6-16 Years)
In hypertensive children aged 6 to 16 years, losartan doses ranging from 2.5 to 100 mg were studied. The results indicated a dose-dependent reduction in diastolic blood pressure, with the most significant effects observed at doses of 25 to 50 mg .
Hypertensive Children (6 Months to 6 Years)
For younger children aged 6 months to 6 years, doses from 0.1 to 0.7 mg/kg per day were evaluated. Although significant blood pressure reductions were observed, no clear dose-response relationship was established, indicating that even lower doses can be effective .
Safety and Tolerability
Losartan is generally well tolerated across different doses. Common adverse effects are minimal, and the drug does not interact significantly with other medications such as hydrochlorothiazide, warfarin, or digoxin . However, it should be avoided during pregnancy due to the risk of fetal toxicity .
Conclusion
Losartan is effective in reducing blood pressure and providing renoprotection in a dose-dependent manner. The optimal dose for most adults appears to be around 50-100 mg daily, while pediatric dosing varies based on age and weight. Overall, losartan is well tolerated, making it a reliable option for managing hypertension and related conditions.
Sources and full results
Most relevant research papers on this topic
Clinical Pharmacokinetics of Losartan
Losartan is a rapidly absorbed oral angiotensin-receptor antagonist with a favorable drug-drug interaction profile, reducing blood pressure effectively and offering end-organ protection without significant adverse effects.
A double-blind, dose-response study of losartan in hypertensive children.
Losartan effectively reduces blood pressure in hypertensive children aged 6-16 years, with a starting dose of 0.75 mg/kg (maximum 50 mg) effectively lowering blood pressure within 3 weeks.
Hemodynamic and Neurohormonal Effects of the Angiotensin II Antagonist Losartan in Patients With Congestive Heart Failure
Losartan causes vasodilation and neurohormonal effects in patients with congestive heart failure, but high doses may not provide additional relief due to neurohormonal activation.
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
Losartan administration (100 mg/day for eight doses over 9 days) leads to treatment-related decreases in blood pressure and increases in plasma renin activity and angiotensin II octapeptide in healthy male volunteers.
Optimal dose of losartan for renoprotection in diabetic nephropathy.
The optimal dose of losartan is 100 mg daily for renoprotection and blood pressure reduction in type 1 diabetic patients with diabetic nephropathy.
DOI